Employers are seeing regular increases in behavioral health usage and costs, which is an encouraging sign after years of underuse driven by stigma and limited access. Increased engagement in care often reflects a workforce that's more aware of mental health needs and more willing to seek appropriate support. However, within this broader positive trend, recent reports have focused on potential overutilization and misbilling in Applied Behavioral Analysis (ABA) claims, a specific area of care delivery for autism spectrum disorders (ASD).
What the reports reveal
The New York Times and the Wall Street Journal have published detailed reports that show possible fraud, waste and abuse among autism ABA therapy vendors. These reports document that some autism vendors have billed for excessive hours of therapy, sometimes far exceeding typical clinical recommendations, or for services that don't appear aligned with evidence-based treatment protocols for ASD. Other concerns include insufficient supervision by licensed clinicians, billing for services not rendered and an overreliance on paraprofessional staff without proper oversight. While these practices aren't representative of most ABA providers, they raise valid questions about consistency, quality and accountability in a treatment area focused on a particularly vulnerable population.
A complex challenge for you and your carriers
This is a complex challenge. On the one hand, coverage of autism-related services is both critical and may be required. Expanding access to these services has been a major step forward for families and reflects broader progress in behavioral healthcare. The Mental Health Parity and Addiction Equity Act doesn't allow differential treatment of mental healthcare. On the other hand, highly visible cases of questionable billing practices contribute to rising costs without clearly improving outcomes, creating potential concerns around value. While some of these published news articles have focused on Medicaid services, overbilling and misbilling impacts commercial plans, too.
Fraud, waste and abuse monitoring is a core responsibility of carriers as administrators of the plan, not simply a service to be passively relied upon. Carriers should have robust oversight practices capable of detecting errant billing patterns, applying medical necessity criteria and ensuring services align with established clinical guidelines. They should also be able to identify and act on issues in real-time. You also play a key role by holding carriers accountable for performing these functions effectively through regular reporting, active oversight and rigorous performance monitoring.
The path forward: What you can do now
Support for evidence-based ABA services is essential, given ABA’s proven role in improving developmental outcomes and supporting families. Simultaneously, you can hold carriers and behavioral health vendors accountable through utilization monitoring, cost driver analysis and strengthened oversight mechanisms. Here are the near-term actions to take:
- Sustain investment in access to evidence-based behavioral healthcare, recognizing its critical role in workforce health, engagement and productivity
- Require health plans to report regularly on ABA usage and act to identify and remove problematic providers from their networks
- Hold carriers accountable for robust fraud, waste and abuse practices that detect errant billing patterns and enable timely intervention
- Watch the evolving regulatory and compliance landscape, particularly as policymakers and payers respond to increased scrutiny
Stay engaged, manage risk
The goal isn't to restrict access to ABA services, but to ensure that care is both appropriate and effective. As scrutiny of the ABA space continues, stay engaged and ask informed questions about quality, outcomes and accountability to sustain meaningful investment in behavioral health while managing risk.
Author
